Table 2

Association between miR-100 expression and clinicopathological parameters of bladder cancer
Clinical features N miR-100 P
Low (n = 78) High (n = 48)
Sex
Male 87 55 (63.2) 32 (36.8) 0.1
Female 39 23 (59.0) 16 (40.9)
Age (years)
≤70 55 30 (54.5) 25 (45.5) 0.08
>70 71 48 (67.6) 23 (32.4)
Stage
Ta 48 20 (41.7) 28 (58.3) 0.01
T1 46 30(65.2) 16 (34.8)
≥T2 32 28 (87.5) 4 (12.5)
Grade
LMP 32 20 (62.5) 12 (37.5) 0.2
LG 43 26(60.5) 17(39.5)
HG 51 32(62.7) 19(37.3)
Carcinoma in situ
Yes 26 18 (69.2) 8(30.8) 0.09
No 100 60 (60.0) 40 (40.0)
Recurrence
Yes 43 36(83.7) 7 (16.3) 0.008
No 73 42 (57.5) 31(42.5)
Progression
Yes 26 20 (76.9) 6 (23.1) 0.01
No 100 58 (58.0) 42(42.0)
Death
Yes 65 62 (95.4) 3 (4.6) < 0.001
No 61 16 (26.2) 45 (73.8)

TUR; transurethral resection; LMP: low malignant potential; LG: low grade; HG: high grade.

Wang et al.

Wang et al. Diagnostic Pathology 2012 7:159   doi:10.1186/1746-1596-7-159

Open Data